Advertisement
Product › Details
Zmax™
Next higher product group | azithromycin (INN) | |
Status | 2005-06-13 registration start | |
Organisation | Pfizer Inc. (NYSE: PFE) | |
Group | Pfizer (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for anti-infective drug_o
- [1] Peptilogics. (12/21/20). "Press Release: Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform". Pittsburgh, PA....
- [2] Peptilogics. (10/1/20). "Press Release: Peptilogics Receives FDA Orphan Drug Designation for Novel Peptide Therapy for the Treatment of Prosthetic Joint Infection"....
- [3] Peptilogics. (2/25/20). "Press Release: Peptilogics Announces CARB-X Funding to Accelerate Development of First-in-Class Antibiotics to Address the Rising Global Threat of Drug-Resistant Bacteria"....
- [4] Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel....
- [5] Peptilogics. (10/15/18). "Press Release: Peptilogics Receives Regulatory Approval to Initiate First-in-Human Safety Study for Therapeutic Peptide PLG0206"....
- [6] Peptilogics. (6/1/18). "Press Release: Peptilogics Receives Qualified Infectious Disease Product Designation from FDA for Lead Compound PLG0206"....
- [7] AiCuris Anti-infective Cures GmbH. (8/1/17). "Press Relase: AiCuris Granted Fast Track Designation by U.S. FDA for Oral Pritelivir for Treatment of HSV Infections in Immunocompromised Adults". Wuppertal....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top